The study by Özdemir et al. showed that α-SMA is a marker for rCAFs, as the depletion of α-SMA+ cells led to enhanced tumor growth in a PDAC mouse model with an increase in Treg to promote antitumor immunity [8]. This evidence concerns the gene ACTA1 and neoplasm.